Cannapharmarx, Inc. (CPMD) — 10-Q Filings

10-Q Filings (6)

• CannaPharmaRx Revenue Soars 262% Amid Widening Losses, CTO Concerns — Nov 14, 2025 Risk: high
  CANNAPHARMARX, INC. reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $1,223,533, up from $338,003 in the prior
• CannaPharmaRx Revenue Jumps, But Liquidity Crisis Deepens Amid CTO — Aug 14, 2025 Risk: high
  CANNAPHARMARX, INC. (CPMD) reported a significant increase in revenue for the six months ended June 30, 2025, reaching $566,927, up from $25,839 in the prior ye
• CannaPharmarx, Inc. Files Q1 2025 10-Q — May 16, 2025 Risk: medium
  CannaPharmarx, Inc. filed its 10-Q for the period ending March 31, 2025. The company, previously known as Concord Ventures, Inc. and CCVG, Inc., is incorporated
• CannaPharmarx, Inc. Files Q3 2024 10-Q — Nov 14, 2024 Risk: low
  CannaPharmarx, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Concord Ventures, Inc., Golden Dragon Holding Co., a
• CannaPharmarx Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  CannaPharmarx, Inc. filed its 10-Q for the period ending June 30, 2024. The company, previously known as Golden Dragon Holding Co., Concord Ventures, Inc., and
• CannaPharmarx Files 10-Q for Q1 2024 — Jun 25, 2024 Risk: medium
  CannaPharmarx, Inc. filed its 10-Q for the period ending March 31, 2024. The company, previously known as Concord Ventures, Inc., is in the pharmaceutical prepa

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX